The present invention relates to a compound of formula (I), provided that this compound is not caffeine, for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising the compound of formula (I). The present invention further relates to new compounds which are dimers of compounds of formula (I).
本发明涉及一种式(I)的化合物,前提是该化合物不是
咖啡因,用于治疗肌张力性疾病类型1和类型2。本发明还涉及包含该式(I)化合物的组合物。本发明还涉及新的化合物,这些化合物是式(I)化合物的二聚体。